Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trastuzumab Deruxtecan in Patients With Advanced Breast Cancer: a Real-world Study

NCT07180264 is registered in ClinicalTrials.gov with Wenjin Yin as lead sponsor.

NCT NCT07180264
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07180264 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trastuzumab Deruxtecan in Patients With Advanced Breast Cancer: a Real-world Study
Lead sponsor
Wenjin Yin
Phase
Observational
Overall status
Recruiting
Start date
August 28, 2025
Completion date
February 28, 2029
Enrollment
118 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced breast cancer